Manual Therapy, Thera-band Exercise and Walking
MTBEW
The Effect of Manual Therapy, Thera-band Exercise and Walking on Age-related Lung Function and Functional Capacity
1 other identifier
interventional
200
1 country
1
Brief Summary
Worldwide, the number of older adults is expected to more than double by 2050 and more than triple by 2100, with most of the increase in developing countries. This situation has become a challenge to health professions such as physical therapy, since aging involves a gradual reduction in the capacity to adapt and an increase in vulnerability to health issues such as chronic non-communicable diseases and musculoskeletal disorders. The respiratory system, as the rest of the body, is exposed to both physiological aging and disease. According to the World Health Organization , respiratory diseases such as trachea, bronchi, or lung cancer, lower respiratory tract infections, or chronic obstructive pulmonary disease are found in the third, fifth, and sixth cause of death, respectively, among the top ten. Therefore, bronchopulmonary and thoracic pathology constitutes an important problem for Public Health, both due to the high number of affected subjects and to their potential severity For this reason, the recommendations of the European, North American and national societies, highlight, among other aspects, the importance of the prevention of these diseases. They also insist on the need to maintain the integrity of the thoraco-abdominal anatomical elements and preventive treatment in those at risk, before symptoms appear. These recommendations together with the change of perspective that is being taken into account when treating aging have led to the fact that in the last decade more research has been started on the respiratory system in older people without respiratory problems. The aim of this trial is to investigate whether manual therapy, elastic band exercise or walking can mitigate the effects of age-related changes in lung function in adults over 60 years old. Also whether there is a difference in effect between the different forms of therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2020
CompletedFirst Posted
Study publicly available on registry
April 14, 2020
CompletedStudy Start
First participant enrolled
October 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2023
CompletedMay 11, 2023
May 1, 2023
3 months
April 5, 2020
May 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pulmonary function
pulmonary function evaluation via forced spirometry dynamic lung volumes (forced vital capacity, FVC; forced expired volume at 1 second, FEV1).
4-8 week
Secondary Outcomes (12)
Chest expansion
4-8 week
Exercise tolerance
4-8 week
Smoking
4-8 week
Musculoskeletal Pain
4-8 week
Perception of change after treatment
4-8 week
- +7 more secondary outcomes
Study Arms (4)
Group1 (G1): walking group
ACTIVE COMPARATORAll walks will be done immediately after the MT and TB intervention, as this has been shown to improve the synergistic effect of combining the two interventions. The walking sessions will be organized twice a week. The walking sessions will begin with a 10-minute warm-up. After warming up, you will take a continuous walk for 10-20 min, at a target intensity of 13 ("somewhat difficult") on the Borg scale. Using the Borg scale, which ranges from 6 to 20, participants will be asked to walk at an intensity of 13 (perception of "somewhat difficult" activity). Each session will be completed with a 10 minute cool down period. The objectives of Walinking will be individualized according to the level of physical condition of each participant. The walking group will include a weekly walking goal of 75 minutes.
Group 2 (G2): walking plus manual therapy
ACTIVE COMPARATORWalking as previously described plus a self-administered manual chest therapy: \- Neurolymphatic points pressure: Participants will be placed in a neutral position and their arms next to their bodies. They are asked to take a conscious breath. The physical therapist will apply firm, direct rotary pressure through the thumb or fingertip for 1 minute from the T1 transverse processes to the T12 transverse processes. Suboccipital decompression / mobilization, slippage of the cervical vertebral joints (anterior / posterior), myofascial release of sternocleidomastoid and trapezius, slippage of the sternoclavicular joint (anterior / posterior direction), myofascial release of intercostal muscles and paravertebral muscles (anterior rib mobilization, posterior, lateral), mobilization of the scapulothoracic joint, diaphragmatic release.
Group 3 (G3): walking plus thorax exercises with Theraband.
ACTIVE COMPARATORWalking as previously described plus a self-administered exercises with elastic-band. The exercises will include chest and arms exercises in sitting position.
Group 4 (G4): control group
NO INTERVENTIONControl group will do usual life and assessments as the rest of the groups.
Interventions
The walking group includes a weekly walking goal of 75 minutes.
Walking plus self-administered thorax manual therapy
Walking plus thorax exercises with Theraband
Eligibility Criteria
You may qualify if:
- Adults between 60-85 years old.
- Male and female
- No history of respiratory or cardiac disease
- Currently non-smoking (\> 6 months)
- Willingness to provide written consent
- Willingness to participate in and comply with study requirements
You may not qualify if:
- Adults over 85 years old.
- History of respiratory pathology.
- History of cardiac pathology.
- Inability to walk unaided and unassisted
- Acute pain on thoracic joint range of motion testing
- Contra-indicated for thoracic mobilisation and/or manipulation (physical screening examination)
- Inability to provide informed consent, e.g. people with a cognitive impairment, intellectual disability or mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gemma Espí
Valencia, 46010, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gemma V Espí-López, Dr
Faculty of Physiotherapy. University of Valencia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 5, 2020
First Posted
April 14, 2020
Study Start
October 25, 2021
Primary Completion
January 30, 2022
Study Completion
April 28, 2023
Last Updated
May 11, 2023
Record last verified: 2023-05